TOP STORIES
rheumatology
Rheumatoid arthritis

Liver toxicity warning for tocilizumab

Serious drug-induced liver injury, including acute liver failure, hepatitis and jaundice, have been observed with the biologic tocilizumab (Actemra), according to the Therapeutic Goods Administration (TGA) In an advisory statement to health professionals, the TGA says serious hepatotoxicity is considered rare, but in some cases treatment has required liver transplant. Tocilizumab is approved for use ...

Already a member?

Login to keep reading.


OR
© 2020 the limbic